Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherImaging (JNMT)

Assessing effect of various blood glucose levels on 18F-FDG activity in the brain, liver and blood pool

Ismet Sarikaya, Ali Sarikaya and Prem Sharma
Journal of Nuclear Medicine Technology June 2019, jnmt.119.226969; DOI: https://doi.org/10.2967/jnmt.119.226969
Ismet Sarikaya
1 Kuwait University Faculty of Medicine Mubarak Al-Kabeer Hospital, Kuwait;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Sarikaya
2 Trakya University Faculty of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prem Sharma
3 Dasman Diabetes Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Objective: Studies have extensively analyzed the effect of hyperglycemia on 18F- fluorodeoxyglucose (18F-FDG or FDG) uptake in normal tissues and tumor. In this study, we measured standardized uptake value (SUV) in the brain, liver and blood pool in normoglycemia, hyperglycemia and hypoglycemia to understand the effect of blood glucose (BG) on FDG uptake and to develop a formula to correct SUV. Material and Methods: Whole body FDG positron emission tomography/computed tomography (PET/CT) images of adults were selected for analysis. Brain SUVmax, blood pool SUVmean and liver SUVmean were measured for the BG ranges of 61-70, 71-80, 81-90, 91-100, 101-110, 111-120, 121-130, 131-140, 141-150, 151-160, 161-170, 171-180, 181-190, 191-200, and 201 mg/dl and above. In each BG range, ten (10) PET images were analyzed (total 150). Mean ± SD of SUV of brain, liver and blood pool in each BG range was calculated and BG/SUV curves were generated. As brain and tumors show high expression of GLUT1 and GLUT3, based on % reduction in brain SUVmax with increasing BG, we generated a formula to correct SUV. Results: Mean brain SUVmax gradually reduced with increasing BG starting after BG level of 110 mg/dl. Approximate % reduction in brain SUVmax was 20%, 35%, 50%, 60%, and 65% for the BG ranges of 111-120, 121-140, 141-160, 161-200, and ≥ 201 mg/dl, respectively. In the formula we generated, measured SUVmax is multiplied by reduction factor of 1.25, 1.5, 2, 2.5 and 2.8 for the BG ranges of 111-120, 121-140 , 141-160 , 161-200 and ≥ 201 mg/dl, respectively, to correct SUV. Brain SUVmax was not different in hypoglycemics as compared to normoglycemics (p>0.05). SUVmean in the blood pool and liver were lower in hypoglycemics (P < 0.05) and not different in hyperglycemicss (p>0.05) as compared to normoglycemics. Conclusion: Hyperglycemia gradually reduces brain FDG uptake starting after BG of 110 mg/dl. Hyperglycemia doesn’t affect FDG activity in the liver and blood pool. Hypoglycemia doesn’t seem to effect brain FDG uptake but appears to reduce liver and blood pool activity. The simple formula we generated can be used to correct SUV in hyperglycemic adults in selected cases.

  • PET
  • PET/CT
  • Blood glucose
  • F-18 FDG
  • blood pool
  • brain
  • liver
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessing effect of various blood glucose levels on 18F-FDG activity in the brain, liver and blood pool
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Assessing effect of various blood glucose levels on 18F-FDG activity in the brain, liver and blood pool
Ismet Sarikaya, Ali Sarikaya, Prem Sharma
Journal of Nuclear Medicine Technology Jun 2019, jnmt.119.226969; DOI: 10.2967/jnmt.119.226969

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessing effect of various blood glucose levels on 18F-FDG activity in the brain, liver and blood pool
Ismet Sarikaya, Ali Sarikaya, Prem Sharma
Journal of Nuclear Medicine Technology Jun 2019, jnmt.119.226969; DOI: 10.2967/jnmt.119.226969
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Pharmacokinetic effects of a single-dose nutritional ketone ester supplement on brain glucose and ketone metabolism in alcohol use disorder
  • SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
  • Interactions between ploidy and resource availability shape clonal interference at initiation and recurrence of glioblastoma
  • Biology of Cancer and PET Imaging: Pictorial Review
  • Assessing PET Parameters in Oncologic 18F-FDG Studies
  • Google Scholar

Similar Articles

Keywords

  • PET
  • PET/CT
  • Blood glucose
  • F-18 FDG
  • blood pool
  • brain
  • liver
SNMMI

© 2025 SNMMI

Powered by HighWire